Combining donor-derived cell-free DNA and donor specific antibody testing as non-invasive biomarkers for rejection in kidney transplantation

Donor specific anti-HLA antibodies (DSA) and donor-derived cell-free DNA (dd-cfDNA) have lead to substantial progress in the non-invasive monitoring of the renal allograft by being able to detect or rule out subclinical rejection and guide immunosuppressive changes. In this study we sought to analyz...

Descripción completa

Detalles Bibliográficos
Autores principales: Obrișcă, Bogdan, Butiu, Maria, Sibulesky, Lena, Bakthavatsalam, Ramasamy, Smith, Kelly D., Gimferrer, Idoia, Warner, Paul, Ismail, Gener, Leca, Nicolae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445050/
https://www.ncbi.nlm.nih.gov/pubmed/36064740
http://dx.doi.org/10.1038/s41598-022-19017-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445050/
https://www.ncbi.nlm.nih.gov/pubmed/36064740
http://dx.doi.org/10.1038/s41598-022-19017-7

Ejemplares similares